Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01657903
Other study ID # Z6961385
Secondary ID
Status Completed
Phase N/A
First received August 2, 2012
Last updated January 22, 2015
Start date November 2011
Est. completion date February 2012

Study information

Verified date July 2014
Source GlaxoSmithKline
Contact n/a
Is FDA regulated No
Health authority United States: Food and Drug Administration
Study type Interventional

Clinical Trial Summary

The purpose of this study is to compare and evaluate the ability of two European Union (EU) regulated gel to foam toothpaste formulations versus a non-fluoride toothpaste using a modified in-situ model of dental erosion and remineralization. A positive control i.e fluoride containing toothpaste marketed in EU will also be compared to non-fluoride toothpaste.


Description:

The aim of this study is to assess the remineralization effects of two EU gel to foam toothpaste formulations with 1450 parts per million (ppm) of fluoride as sodium fluoride (NaF) and 5% potassium nitrate (KNO3) versus a non-fluoride (0 ppm F)/KNO3 toothpaste as a negative control. The two experimental gel to foam toothpaste formulations differ in their relative dentine abrasivity (RDA) values which is an in-vitro measure of a toothpaste abrasivity to the dentinal tissues. A marketed toothpaste containing NaF and KNO3 will serve as a positive control.


Recruitment information / eligibility

Status Completed
Enrollment 56
Est. completion date February 2012
Est. primary completion date February 2012
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- General and Oral Health: Good general health with (in the opinion of the investigator) no clinically OST and OHT examinations.

- Oral Requirements:

- An intact maxillary dental arch suitable for the retention of the palatal appliance and an intact mandibular dental arch. Subjects may have fixed bridges replacing missing teeth.

- A gum base stimulated whole saliva flow rate = 0.8 g/min and an unstimulated whole saliva flow rate = 0.2 g/min.

- Contraception: Women of childbearing potential who are, in the opinion of the investigator, practicing a reliable method of contraception.

Exclusion Criteria:

- Oral Health:

- Current active caries or periodontal disease that may compromise the study or the health of the subjects.

- Lesions of the oral cavity that could interfere with the study evaluations, including severe gingivitis, grossly carious lesions, periodontitis and other severe periodontal disease.

- Allergy/Intolerance: Known or suspected intolerance or hypersensitivity to the study materials (or closely related compounds) or any of their stated ingredients.

- Clinical Study/Experimental Medication:

- Participation in another clinical study or receipt of an investigational drug within 30 days of the screening visit

- Previous participation in this study

- Substance abuse: Recent history (within the last year) of alcohol or other substance abuse.

- Pregnancy: Women who are pregnant or who are intending to become pregnant over the duration of the study

- Breast-feeding: Women who are breast-feeding

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Drug:
Sodium Fluoride
Toothpaste containing 1450 ppm F - EU level as NaF.
Potassium nitrate
All study treatments contain 5% w/w KNO3.

Locations

Country Name City State
United States Indiana University School of Dentistry Indianapolis Indiana

Sponsors (1)

Lead Sponsor Collaborator
GlaxoSmithKline

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other RER of Enamel Specimens Post 2 Hours of Treatment Exposure Enamel specimens were exposed to dietary erosive challenge and set of five indentations within each specimen was measured. Decrease in the indentation length compared to the baseline indicates hardening of enamel surface. Enamel specimens were exposed to second erosion challenge to determine RER which compared the indentations values of enamel specimens at baseline (B), first erosive (E1) and second erosive challenge (E2). Percent RER was calculated by formula: [(E1-E2)/ (E1-B)]*100. Smaller the negative RER, better is treatment regimen in imparting resistance to enamel. Baseline, 2 hours post treatment in each treatment period No
Other SMH Recovery of Enamel Specimens Post 2 Hours of Treatment Exposure SMH test was used to assess mineralization status of enamel specimens using a Wilson 2100 Hardness tester. SMH was determined by measuring the length of the indentations of enamel specimens. An increase in the indentation length compared to the baseline indicates softening while decrease in the indentation length represents rehardening of enamel surface. Percent SMH recovery was calculated from indentation values of enamel specimens at baseline (B), after in-situ hardening (R) and after first erosive challenge (E1) using formula: [(E1- R)/ (E1-B)]*100. A higher percentage values indicate a better outcome. Baseline, 2 hours post treatment in each treatment period No
Primary Relative Erosion Resistance (RER) of Enamel Specimens Post 4 Hours of Treatment Exposure Enamel specimens were exposed to dietary erosive challenge and set of five indentations within each specimen was measured. Decrease in the indentation length compared to the baseline indicates hardening of enamel surface. Enamel specimens were exposed to second erosion challenge to determine RER which compared the indentations values of enamel specimens at baseline (B), first erosive (E1) and second erosive challenge (E2). Percent RER was calculated by formula: [(E1-E2)/ (E1-B)]*100. Smaller the negative RER, better is treatment regimen in imparting resistance to enamel. Baseline, 4 hours post treatment in each treatment period No
Primary Surface Microhardness (SMH) Recovery of Enamel Specimens Post 4 Hours of Treatment Exposure SMH test was used to assess mineralization status of enamel specimens using a Wilson 2100 Hardness tester. SMH was determined by measuring the length of the indentations of enamel specimens. An increase in the indentation length compared to the baseline indicates softening while decrease in the indentation length represents rehardening of enamel surface. Percent SMH recovery was calculated from indentation values of enamel specimens at baseline (B), after in-situ hardening (R) and after first erosive challenge (E1) using formula: [(E1- R)/ (E1-B)]*100. A higher percentage values indicate a better outcome. Baseline, 4 hours post treatment in each treatment period No
See also
  Status Clinical Trial Phase
Completed NCT04208802 - Effect of Smoking on Saliva Composition and the Development of Dental Erosion
Not yet recruiting NCT04033263 - Maintaining Oral Health With Bio-products N/A
Completed NCT00752089 - Experimental Dentifrice Remineralization/Fluoride Uptake in an in Situ Model Phase 2
Completed NCT01167543 - Relationship and Pathophysiology of Gastroesophageal Reflux and Dental/Periodontal Disease N/A
Completed NCT04095520 - 12 Months Clinical Follow-up of Non-Carious Cervical Lesions Restored With New Injectable Composite N/A
Completed NCT03311438 - Oral Health Intervention Program for Children With Congenital Heart Defects N/A
Completed NCT04586322 - Association Between Erosive Tooth Wear Progression and Dietary Risk Factors.
Enrolling by invitation NCT06156618 - The Effect of Nitrate Supplement on the Oral Microbiome and Saliva in Dental Erosion N/A
Suspended NCT02775149 - Dental Erosion in Patients With Gastro-oesophageal Reflux
Active, not recruiting NCT05371717 - Domiciliary Management of Dental Erosion in Patients With GERD With Biomimetic Hydroxyapatite N/A
Not yet recruiting NCT04602572 - Obesity and Oral Diseases in Adult Patients
Completed NCT02780973 - Influence of Gender Specific Differences of Saliva Composition on the Development of Dental Erosion - an In-situ Study
Completed NCT03426150 - Casein Phosphopeptide--amorphous Calcium Phosphate on Human Enamel Subjected to in Vivo Acid Attacks Phase 4
Not yet recruiting NCT06171594 - The Effect of Chlorhexidine on the Oral Microbiome and Saliva in Dental Erosion N/A
Completed NCT05140538 - A New Protocol for the Management of Dental Erosion in Rugby Players N/A
Recruiting NCT02087345 - Gastro-oesophageal Reflux in Oligosymptomatic Patients With Dental Erosion